Company News
04/08/2022
Virginia Western to launch new 2-year biotechnology degree
Roanoke, VA (The Roanoke Times) – Virginia Western Community College announced this week it will be launching a new biotechnology degree program to keep pace with the region’s fast-growing industry. Students will earn a two-year associate degree in biotechnology that will prepare them to transfer to a four-year school for a bachelor’s degree or to …
04/06/2022
ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN
ATCC’s collection of high-fidelity, authenticated DNA-seq and RNA-seq datasets to be included in QIAGEN’s databases for biotechnology and pharmaceutical companies for research Manassas, VA, United States, ATCC, the world’s premier biological materials management and standards organization, today announced that it has entered into an agreement with QIAGEN, a recognized leader in bioinformatics solutions, to provide …
04/05/2022
Governor Glenn Youngkin Announces Sports Medicine Company to Expand in the City of Norfolk, Creating 92 New Jobs
RICHMOND, VA (Office of Governor Glenn Youngkin) – Governor Glenn Youngkin today announced that Embody, Inc., a Norfolk-based medical device company developing novel collagen-based technologies for soft tissue repair, will invest $5 million to expand its headquarters at Innovation Research Park at Old Dominion University in the City of Norfolk. The company will add 10,000 …
03/25/2022
One of World’s Top Innovators Joins Focused Ultrasound Foundation as Chief Technology Officer
Charlottesville, Va., – Rick Hamilton, a leading inventor and authority on technology and innovation, has joined the Foundation as Managing Director and Chief Technology Officer. Hamilton is the one of the world’s most prolific inventors with more than 1,040 patents, standing just behind Thomas Edison. He has spent nearly 30 years at Fortune 50 organizations and …
03/22/2022
Carilion Clinic, Richmond firm part of $3.5M concussion grant
Clinical trial to follow 300 patients Roanoke, VA (Virginia Business) – Roanoke-based Carilion Clinic and Richmond’s BRAINBox Solutions Inc. are part of a $3.5 million National Institutes of Health grant to research and develop a new way to diagnose brain injuries in the elderly. The research will include enrolling 300 patients with head trauma and …
03/16/2022
ZielBio Announces First Patient Dosed in Phase 1/2 Clinical Trial of ZB131, Its Novel Monoclonal Antibody Targeting Cancer Specific Plectin
First-in-human, open-label, dose escalation study will evaluate ZB131 in patients who have solid tumors with high CSP expression ZB131 clinical trial open and enrolling patients CHARLOTTESVILLE, Va./PRNewswire/ — ZielBio, Inc., a clinical stage biotechnology company discovering new treatments for cancer through its innovative ZielFind drug discovery platform, today announced the first patient dosed in its …
03/14/2022
VIPC Regional Innovation Fund Grant Awarded to Charlottesville BioHub to Strengthen the Entrepreneurial Ecosystem in the Charlottesville Region
Funding will further Charlottesville BioHub’s goals to advance entrepreneurship in the area’s biotechnology sector and support tech and other innovation-led sectors with resourcing and connection Charlottesville, Virginia – Charlottesville BioHub, an industry-led 501c3 nonprofit organization dedicated to strengthening Charlottesville’s biotechnology industry sector, today announced that it has received a $200,000 grant from the Virginia Innovation Partnership Corporation’s …
03/10/2022
Virginia Tech and Amazon establish machine learning research partnership
Virginia Tech and Amazon are partnering to advance research and innovation in artificial intelligence and machine learning. The Amazon – Virginia Tech Initiative for Efficient and Robust Machine Learning will include machine learning-focused research projects, doctoral student fellowships, community outreach, and an establishment of a shared advisory board. “This partnership affirms the value of our …
03/09/2022
Phlow Launches Key Essential Medicines to Leading Children’s Hospitals to Help Alleviate Impact of Shortages
RICHMOND, Va.–(BUSINESS WIRE)–Phlow, a U.S.-based, public benefit impact-driven pharmaceutical company, announced the launch of key essential medicines, sequentially over the coming quarter, for the Children’s Hospital Coalition™ (CHC), a first-in-kind coalition of leading pediatric institutions. The availability of these medications is an important first step demonstrating Phlow’s commitment to CHC members to provide a reliable …
03/03/2022
BIO-CAT Microbials Invests $35 Million in State-of-the-Art Virginia Fermentation Facility
TROY, Va., /PRNewswire/ — BIO-CAT Microbials, LLC — a Virginia-based leading microbial solutions company — recently announced a $35 million investment to significantly expand its Troy, Virginia facility to include fermentation capabilities. The company will be breaking ground on an initial 53,800 square-foot expansion phase in March of 2022, with potential future expansion up to an additional 100,000 square feet. The expansion …
03/03/2022
Civica to Manufacture and Distribute Affordable Insulin
Americans with diabetes will have access to more affordable insulins through a transparent, cost-plus model Drastically reducing out-of-pocket costs for insulin through transformative collaboration between Civica and dedicated partners representing nearly every corner of the diabetes ecosystem LEHI, Utah –(BUSINESS WIRE)–Civica, Inc. (Civica, Civica Rx) today announced plans to manufacture and distribute insulins that, once …
03/02/2022
FDA Approves Kaléo’s 10 mg Naloxone Auto-Injector for the Treatment of Known or Potential Exposure to Ultra-Potent Weaponized Opioids
Product Received Fast-Track Designation for military personnel facing the potential threat of exposure to synthetic opioids on the battlefield on behalf of the U.S. Department of Defense. RICHMOND, Va.–(BUSINESS WIRE)–Kaléo, a privately held U.S. pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Naloxone Auto-injector 10 mg (NALOXONE HYDROCHLORIDE …
03/02/2022
Tom Ryder Joins Focused Ultrasound Foundation Board of Directors
CHARLOTTESVILLE, VA – Thomas O. Ryder, an investor, entrepreneur, and retired corporate executive, was elected to the Focused Ultrasound Foundation’s Board of Directors at their March 1 meeting. Ryder has served as Chairman and CEO of the Reader’s Digest Association and President of American Express’s Travel Related Services International, Merchant Services Worldwide, and American Express Publishing …
02/28/2022
Pharma Cluster Accelerator Announces New Diversity, Equity and Inclusion Lead
New position ensures access to opportunities created by the Advanced Pharmaceutical Research and Manufacturing Cluster regardless of race, ethnicity, gender, or geographic location. Richmond, VA – The Cluster Accelerator for Advanced Pharmaceutical Research and Manufacturing, an entity launched to fast-track the development of a globally competitive essential medicines manufacturing hub across Central Virginia, announced the hiring …
02/25/2022
Lighthouse Labs Announces Newest Cohort
Three Richmond-area companies — a maker of ingredient-conscious lipstick and lip balms, a company that helps connect expectant and new parents to care providers, and a firewood delivery service — were selected to participate in a Richmond accelerator program for startup companies. The three Richmond businesses will join six others — including two from elsewhere …
02/23/2022
KeViRx, Inc selected as part of BLUE KNIGHT™ collaboration for global health preparedness
Charlottesville, Virginia – KeViRx, Inc. (“KeViRx”) has been selected to join Blue Knight, a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), a component of the U.S. Department of Health and Human Services. Blue Knight is a collaborative program designed to anticipate and respond to …
02/22/2022
Chandra Briggman column: Filling the nation’s need for essential medicines
Richmond, VA, (Richmond Times Dispatch) – While many of us have been focused this month on the Olympics and Super Bowl, another competition is underway that could make an enormous impact on our community and nation. The Build Back Better Regional Challenge is a historic grant competition issued by the U.S. Economic Development Administration. BBBRC …
02/22/2022
CEE to Host STEM Lyceums Events for Students
McLean, Va. – The Center for Excellence in Education (CEE) announces its spring 2022 schedule of virtual science, technology, engineering, and mathematics (STEM) Lyceums events for high school students. CEE’s STEM Lyceums are free monthly virtual meetings that will engage high school students in discussion and exploration of STEM concepts and unique STEM career pathways, provided …
02/16/2022
Children’s National uses HIFU to perform first ever non-invasive brain tumor surgery
Washington, D.C., Children’s National Hospital successfully performed the first-ever high-intensity focused ultrasound (HIFU) surgery on a pediatric patient with neurofibromatosis (NF). This is the youngest patient to undergo HIFU treatment in the world. The advancement of children’s medical devices in the U.S. continues to significantly lag behind adult devices. This is why this milestone marks …
02/16/2022
TearSolutions, Inc. Announces Outcome of Type C Meeting with FDA and Next Steps in the Development of Lacripep™
CHARLOTTESVILLE, Va., (GLOBE NEWSWIRE) — TearSolutions, Inc. (“the Company”), a privately held developer of a replacement therapy for the treatment of Dry Eye Disease (DED) called Lacripep, today announced that in late 2021 it received official minutes from a Type C meeting with the U.S. Food and Drug Administration (FDA) regarding the development of Lacripep …
02/16/2022
ADIAL PHARMACEUTICALS ANNOUNCES CLOSING OF $10 MILLION FINANCING
CHARLOTTESVILLE, Va., (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the closing of its previously announced registered direct offering, whereby a single accredited institutional investor purchased approximately $10 million of …
02/16/2022
ZielBio Announces First Patient Dosed in Phase 1/2 Clinical Trial of ZB131, Its Novel Monoclonal Antibody Targeting Cancer Specific Plectin
CHARLOTTESVILLE, Va., /PRNewswire/ — ZielBio, Inc., a clinical stage biotechnology company discovering new treatments for cancer through its innovative ZielFind drug discovery platform, today announced the first patient dosed in its Phase 1/2 clinical trial. The study will evaluate ZB131 in patients with solid tumors who are either non-responsive to or ineligible for the standard …
02/16/2022
ATCC Announces Awards from DTRA that Strengthen ATCC’s Antiviral Drug Discovery and Development Portfolio for Global Health and Biodefense
Manassas, VA, ATCC, the world’s premier biological materials management and standards organization, announced that it has been awarded three grants valued at over $5.5 million by the Defense Threat Reduction Agency (DTRA). The work will identify and characterize novel therapeutic approaches to viruses of global health concern. Promising therapeutic candidates will be tested for efficacy with …
02/16/2022
ATCC Announces Awards from DTRA that Strengthen ATCC’s Antiviral Drug Discovery and Development Portfolio for Global Health and Biodefense
Manassas, VA, ATCC, the world’s premier biological materials management and standards organization, announced that it has been awarded three grants valued at over $5.5 million by the Defense Threat Reduction Agency (DTRA). The work will identify and characterize novel therapeutic approaches to viruses of global health concern. Promising therapeutic candidates will be tested for efficacy with in …